Vivo Ventures VI LLC 13D and 13G filings for Eiger BioPharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 5:23 pm Sale | 2021-12-31 | 13D | Eiger BioPharmaceuticals, Inc. EIGR | Vivo Ventures VI LLC | 139 13.000% | -55,431 (-99.75%) | Filing |
| 2021-08-06 4:30 pm Sale | 2021-08-05 | 13D | Eiger BioPharmaceuticals, Inc. EIGR | Vivo Ventures VI LLC | 55,570 4.910% | -4,000 (-6.71%) | Filing |
| 2021-02-12 4:30 pm Unchanged | 2020-12-31 | 13D | Eiger BioPharmaceuticals, Inc. EIGR | Vivo Ventures VI LLC | 59,570 5.500% | 0 (Unchanged) | Filing |